Filing Details

Accession Number:
0001209191-14-009775
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-12 16:51:59
Reporting Period:
2014-02-10
Filing Date:
2014-02-12
Accepted Time:
2014-02-12 16:51:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1131324 Genomic Health Inc GHDX Services-Medical Laboratories (8071) 770552594
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1337798 Bradley G Cole 301 Penobscot Drive
Redwood City CA 94063
Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-10 3,000 $2.88 27,789 No 4 M Direct
Common Stock Disposition 2014-02-10 3,000 $27.00 24,789 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2014-02-10 3,000 $0.00 3,000 $2.88
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
11,337 2014-12-02 No 4 M Direct
Footnotes
  1. These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 22, 2013.
  2. Represents actual sale price.
  3. Includes 6,750 restricted stock units awarded on January 27, 2011, of which vest 1/3 of the shares vest on February 15, 2014, and 1/3 of the shares that vested on each of February 15, 2012 and 2013, net of withholding.
  4. Includes 6,700 restricted stock units awarded February 5, 2012,of which 1/3 vest on each of February 15, 2014 and 2015, and the 1/3 of the shares that vested on February 15, 2013, net of withholding.
  5. Includes 6,000 restricted stock units awarded July 25, 2013, of which 1/3 of the shares vest on each of February 15, 2014, 2015 and 2016.
  6. The option became exercisable as to 25% of the shares on December 2, 2005, and becomes exercisable as to 1/48th of the shares each full month thereafter.